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We report the crystal structures of the phosporylated
pyruvate dehydrogenase (E1p) component of the
human pyruvate dehydrogenase complex (PDC). The
complete phosphorylation at Ser264-a (site 1) of a
variant E1p protein was achieved using robust pyru-
vate dehydrogenase kinase 4 free of the PDC core.
We show that unlike its unmodified counterpart, the
presence of a phosphoryl group at Ser264-a prevents
the cofactor thiamine diphosphate-induced ordering
of the two loops carrying the three phosphorylation
sites. The disordering of these phosphorylation loops
is caused by a previously unrecognized steric clash
between the phosphoryl group at site 1 and a nearby
Ser266-a, which nullifies a hydrogen-bonding net-
work essential for maintaining the loop conforma-
tions. The disordered phosphorylation loops impede
the binding of lipoyl domains of the PDC core to
E1p, negating the reductive acetylation step. This re-
sults in the disruption of the substrate channeling in
the PDC, leading to the inactivation of this catalytic
machine.
INTRODUCTION
The human pyruvate dehydrogenase complex (PDC) catalyzes
the oxidative decarboxylation of pyruvate to produce acetyl-
CoA and NADH (reaction 1) and is the gatekeeper enzyme that
strategically links glycolysis to the Krebs cycle and lipogenic
pathways (Patel and Roche, 1990; Reed, 2001).
PDC is a 9.5 3 106-dalton multienzyme complex organized
around a dodecahedral core formed by 60 combined dihydroli-
poyl transacetylase (E2p) and E3-binding protein (E3BP) sub-
units. To this E2p/E3BP core, multiple copies of the thiamin di-
phosphate (ThDP)-dependent pyruvate dehydrogenase (E1p)
component, the FAD-containing dihydrolipoamide dehydroge-
nase (E3) component, and one to two copies each of pyruvate
dehydrogenase kinase (PDK) and pyruvate dehydrogenase
phosphatase (PDP) are tethered via noncovalent interactionsStructure 16, 1849–185(Reed, 2001; Roche and Hiromasa, 2007). Reaction steps cata-
lyzed by the three catalytic components (E1p, E2p, and E3) of
PDC, which are functionally linked through substrate channeling,
are as follows:
CH3-CO-COOH+CoA-SH+NAD
+/CH3-CO-
S-CoA +CO2[+NADH+N
+ (1)
CH3-CO-COOH+ThDP/CH3-COH=ThDP+CO2[ (2)
CH3-COH=ThDP+ ½lipS2/½CH3-CO-S-lipSH+ThDP (3)
½CH3-CO-S-lipSH+CoA-SH/CH3-CO-S-CoA +

lipðSHÞ2

(4)

lipðSHÞ2

+FAD/½lipS2+FADH2 (5)
FADH2 +NAD
+/FAD+NADH+H+ (6)
The E1p component catalyzes the ThDP-mediated decarbox-
ylation of pyruvate (reaction 2) and the reductive acetylation of
a lipoyl group ([lipS2]) covalently linked to the lipoyl-bearing do-
mains (LBDs) of E2p and E3BP (reaction 3). The acetylated
LBDs ([CH3-CO-S-lipSH]) serve as ‘‘swinging arms’’ (Perham,
2000) to transfer the acetyl group from E1p to the E2p active
site, where it is converted to acetyl-CoA (reaction 4). Finally,
the E3 component reoxidizes the dihydrolipoyl moiety on LBDs
([lip(SH)2]) with NAD
+ as the ultimate electron acceptor (reactions
5 and 6).
Phosphorylation/inactivation of the PDC by pyruvate dehydro-
genase kinase (PDK), discovered in late 1960s, was among the
first examples of enzyme regulation by reversible phosphoryla-
tion (Linn et al., 1969). Since then, phosphorylation of the PDC
has been shown to play a pivotal role in regulating carbohydrate
and lipid metabolism (Harris et al., 2002; Sugden and Holness,
2003). Starvation and diabetes increase phosphorylation that in-
activates PDC, leading to impaired glucose oxidation (Holness
et al., 2000; Kwon et al., 2004; Wu et al., 1999). Prevention of
PDC phosphorylation by the specific PDK inhibitor dichloroace-
tate increases levels of reactive oxygen species in mitochondria,9, December 10, 2008 ª2008 Elsevier Ltd All rights reserved 1849
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Crystal Structures of Phospho-E1p ComponentFigure 1. Overall Structure of the Wild-type
E1p Heterotetramer
A stereo diagram of the crystal structure of the
wild-type E1p heterotetramer (a2b2) is shown as
surface representation models with each of the
four subunits represented by a different color.
The two phosphorylation loops (Ph-loops) are
shown as ribbon models with Ph-loop A in orange
and Ph-loop B in yellow. The three phosphoryla-
tion sites in each a subunit are depicted by
spheres and labeled according to the site num-
bers. The red triangle indicates the entrance of
the active-site channel where substrates pyruvate
and lip-LBD enter. The axis of twofold symmetry in
the heterotetramer is indicated by a gray arrow.which promotes the expression of a mitochondria-K+ channel
axis, leading to cellular apoptosis and the inhibition of tumor
growth (Bonnet et al., 2007; Cairns et al., 2007). Therefore, the
regulation of the PDC flux by reversible phosphorylation is po-
tentially a novel drug target for obesity, type 2 diabetes, and can-
cer (Pan and Mak, 2007; Sugden, 2008; Sugden and Holness,
2003).
To date, four PDK isoforms (1–4) in mammalian mitochondria
have been identified (Popov et al., 1997). PDK isoforms are re-
cruited to the PDC by preferentially binding to the inner LBD
(L2) of the E2p subunit with concomitant increased kinase activ-
ity (Roche and Hiromasa, 2007). Colocalization of PDKs with the
E1p substrate bound to the subunit-binding domain (SBD) of E2p
results in enhanced PDK activity (Roche et al., 2003). In addition,
conformational changes of PDK3 induced by L2 binding foster
stimulation of PDK3 activity through facilitated ADP/ATP ex-
change, which removes product inhibition exerted by ADP
(Bao et al., 2004; Kato et al., 2005). PDK4 has the lowest affinity
for L2 and is only minimally stimulated by the E2p/E3BP core
(Roche and Hiromasa, 2007). PDK4 was recently shown to
possess the highest kinase activity among the four PDK iso-
forms, regardless of the presence of L2 or the E2p/E3BP core
(Wynn et al., 2008).
Phosphorylation of the heterotetrameric (a2b2) E1p compo-
nent by PDK isoforms occurs at three serine residues of the
a subunit (Ser264-a: site 1; Ser271-a: site 2; and Ser203-a:
site 3) (Figure 1; Sale and Randle, 1981a; Teague et al., 1979;
Yeaman et al., 1978). Crystal structures of human E1p have
shown that sites 1 and 2 are located in the conserved phosphor-
ylation loop A (Ph-loop A, residues 259-a to 282-a) (Ciszak et al.,
2003), which forms one wall of the E1p active-site channel and
helps anchor the cofactor ThDP to the active site. Site 3 is lo-
cated in a short loop segment (residues 198-a to 205-a), termed
phosphorylation loop B (Ph-loop B) adjacent to Ph-loop A. Ph-
loop B also provides coordination to a Mg2+ ion chelated by
the diphosphate group of ThDP. Phosphorylation of any of the
three sites alone inactivates E1p, with site 1 being most rapidly
phosphorylated and site 3 the slowest (Korotchkina and Patel,
1995; Sale and Randle, 1981a). Each PDK isoform exhibits differ-
ent site specificity. Using E1p mutants with single functional1850 Structure 16, 1849–1859, December 10, 2008 ª2008 Elsevierphosphorylation sites, it was shown that all four isoforms phos-
phorylate sites 1 and 2, but only PDK1 phosphorylates site 3
(Kolobova et al., 2001; Korotchkina and Patel, 2001a).
Despite the discovery of PDC regulation by phosphorylation
four decades ago and its clinical ramifications for diabetes and
cancer, the structural basis for inactivation of the PDC by phos-
phorylation remains unknown. This presumably has resulted
from the difficulty until now to obtain a fully phosphorylated
E1p component, due to half-of-the-sites phosphorylation when
the reaction is carried out in the presence of the E2p/E3BP
core (Kolobova et al., 2001; Korotchkina and Patel, 2001b; Sug-
den et al., 1978). We have previously shown that the phosphor-
ylation of Ser291-a (site 1) in the related E1b component of the
human branched-chain a-ketoacid dehydrogenase complex
(BCKDC) blocks the ThDP-induced ordering of the single Ph-
loop, which corresponds to Ph-loop A in E1p, carrying both
Ser291-a (site 1) and Ser302-a (site 2) (Wynn et al., 2004). This
conformational change abolishes the binding of LBD in the E2b
component of BCKDC to the E1b component, resulting in the in-
activation of BCKDC. However, because the loop in phosphory-
lated E1b is not visible, the structural basis underlying the disor-
dering of the loop in phosphorylated E1b is not clear. With
respect to the human PDC, a recent study showed that the sub-
stitution of Ser264-a (site 1) in the E1p component with a bulky,
negatively charged glutamate residue impedes active site
accessibility, but Ph-loop A in this S264E-a mutant remains fully
ordered (Seifert et al., 2007). It was proposed that the inaccessi-
bility of substrates pyruvate and lipoylated LBD, and by extra-
polation not a disordered Ph-loop, is responsible for inactivation
of the PDC by phosphorylation. However, the bona fide mecha-
nism for PDC inactivation by phosphorylation remains uncertain
and controversial because the structure of phosphorylated E1p
has not been determined.
In the present study, we approached the mechanism for inac-
tivation of PDC by deciphering crystal structures of a phophory-
lated E1p variant, in which sites 2 and 3 are eliminated by alanine
substitutions (Korotchkina and Patel, 1995). The complete phos-
phorylation at Ser264-a (site 1) of this E1p variant was accom-
plished, for the first time, using isolated PDK4 free of the
E2p/E3BP core. The robust basal activity of PDK4 (Wynn et al.,Ltd All rights reserved
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out geometric constraints imposed by the E2p/E3BP core. Crys-
tal structures of the phosphorylated site 1-only E1p variant reveal
the presence of disordered conformations for Ph-loops A
and B, despite the presence of the bound cofactor ThDP. Seren-
dipitously, some of the Ph-loops in the phosphorylated E1p mu-
tant become ordered due to crystal packing. This allows a visual-
ization of the phosphoryl group on Ph-loop A, which potentially
poses a previously unrecognized steric clash with a close-by
Ser266-a residue. These clashes eliminate an essential hydro-
gen-bonding network for stabilizing the loop conformation, re-
sulting in the disordered Ph-loops. The present findings suggest
that the phosphoryl group-induced disordering of the Ph-loops is
the underlying mechanism for inactivation of the PDC and the re-
lated BCKDC by phosphorylation. This mechanism fundamen-
tally differs from the one previously described based on an or-
dered Ph-loop A in the structure of the phosphomimetic
mutant S264E-a E1p (Seifert et al., 2007).
RESULTS AND DISCUSSION
Complete Phosphorylation of E1p Variants by PDK4
As described, each a subunit of human E1p carries three phos-
phorylation sites (site 1: Ser264-a; site 2: Ser271-a; and site 3:
Ser203-a), resulting in six total phosphorylation sites in the E1p
a2b2 heterotetramer. To obtain uniformly phosphorylated E1p
preparations, E1p variants containing only phosphorylation site 1
(S1-E1p) or site 2 (S2-E1p) were produced, in which the re-
maining two sites were inactivated by alanine substitutions (Kor-
otchkina and Patel, 1995). Previous studies indicated that only
50% phosphorylation was achieved, when the S1-E1p or the
S2-E1p single-site variant and the various PDK isoforms were
both docked to the E2p/E3BP core (Kolobova et al., 2001; Kor-
otchkina and Patel, 2001b). These findings are consistent with
the earlier report of half-of-the-sites phosphorylation with wild-
type E1p, where only three of the six phosphorylation sites in
Figure 2. Time Course for Phosphorylation
of E1p Variants by PDK4
E1p variants S1-E1p and S2-E1p contain phos-
phorylatable site 1 and site 2, respectively. The
remaining two phosphorylation sites in each E1p
variant were mutated to alanine. S1-E1p (C) and
S2-E1p (,) were phosphorylated by PDK4 in the
absence of the E2p/E3BP cores as described in
Supplemental Experimental Procedures. The
amount of [32P] phosphate incorporated per E1p
heterotetramer was converted to percent phos-
phorylation. Each variant E1p heterotetramer has
two phosphorylatable serine residues; therefore,
100% phosphorylation indicates that both serine
residues in the heterotetramer are phosphorylated.
the E1p heterotetramer were modified
(Sugden and Randle, 1978). Apparent
nonequivalent-site phosphorylation was
also observed with the E1b component
of the BCKDC. It was suggested that
the positional effects occur when both
E1b and BCKD kinase are tethered to
the 24-meric E2b core; as a result, only the phosphorylation
site proximal to the kinase is phosphorylated (Li et al., 2007).
Human PDK4 is capable of robustly phosphorylating free E1p
in the absence of the E2p/E3BP cores (Wynn et al., 2008). Free
S1-E1p or S2-E1p was incubated for up to 120 min with
[g-32P]ATP and PDK4 with a molar ratio of E1p:PDK4 = 2:1.
The incorporation of [g-32P] into the E1p-a subunit was analyzed
by SDS-PAGE and phosphorimaging (Figure 2). Nearly 100%
phosphorylation at sites 1 and 2 with the S1-E1p and S2-E1p
mutants, respectively, was achieved within 20 min. The data in-
dicate that half-site phosphorylation does not occur when these
E1p variants are phosphorylated by PDK4 in the absence of the
E2p/E3BP cores. The scaled-up fully phosphorylated S1-E1p
(phospho-S1-E1p) was used in the following kinetic and crystal-
lographic studies.
Phosphorylation of S1-E1p Abolishes Activities
for Reductive Acetylation and the Overall Reaction
Enzyme kinetic studies of wild-type E1p, S1-E1p, and phospho-
S1-E1p were carried out by measuring activities for the overall re-
action (reaction1), E1p-catalyzed decarboxylation (reaction2), and
E1p-catalyzed reductive acetylation (reaction 3; Table 1). In all the
assays, cofactor ThDP is present at a saturating concentration
(2 mM). With pyruvate as the variable substrate, S1-E1p exhibits
slightly reduced kcat (17.8 s
1) for the overall reaction when recon-
stituted with E2p/E3BP and E3, compared with wild-type E1p
(21 s1). TheKm value of S1-E1p for pyruvate (58mM) is 40% higher
than that of the wild-type (41 mM). These findings indicate that
S1-E1p is similar to wild-type E1pwith respect tokcat andKm values
for pyruvate. As expected, phospho-S1-E1p nullifies the overall
activity of the PDC, when reconstituted with E2p/E3BP and E3.
When E1p-catalyzed decarboxylation activity (reaction 2) was
assayed in the presence of the artificial electron acceptor 2,6-
dichlorophenolindophenol (DCPIP), wild-type and S1-E1p again
exhibited similar kcat and Km values for pyruvate (Table 1). With
phospho-S1-E1p, the kcat value for pyruvate is decreased fromStructure 16, 1849–1859, December 10, 2008 ª2008 Elsevier Ltd All rights reserved 1851
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Crystal Structures of Phospho-E1p Componentthe corresponding values for wild-type E1p and S1-E1p by 19%
and 32%, respectively. Significantly, the Km value for pyruvate of
phospho-S1-E1p (281 mM) is increased about 30-fold compared
with those of the wild-type E1p (8.1 mM) and S1-E1p (9.5 mM).
This finding indicates that phosphorylation drastically reduces
the affinity of phosphorylated S1-E1p for the substrate pyruvate.
In parallel experiments, E1p-catalyzed reductive acetylation
(reaction 3) was assayed by determining the rate of incorporation
of the hydroxyacetyl moiety from [U-C14]pyruvate into the
reduced lipoylated L2 domain. Wild-type E1p and S1-E1p
show essentially identical kcat values for reductive acetylation
of 0.03 s1 (Table 1). Notably, phosphorylation of S1-E1p re-
duces reductive acetylation activity to nonmeasurable levels.
The above findings represent the first kinetic parameters
obtained with the fully phosphorylated E1p protein. The data are
similar to those obtained with the pseudophosphorylated S264E-
aE1p mutant (Seifert etal., 2007).The 30-fold increase inKm forpy-
ruvate with phospho-S1-E1p (Table 1) is consistent with the
20-fold increase in the apparentdissociation constant (Kd) for bind-
ing of the pyruvate analog methylacetylphosphonate (MAP) to the
S264E-a E1p variant, compared with wild-type E1p (Seifert et al.,
2007). Both S264E-a and S264Q-a E1p variants were essentially
devoid of activity for reductive acetylation, also similar to phos-
pho-S1-E1p (Table 1). In the study of Seifert et al. (2007), it was
suggested that the presence of a bulky and/or negatively charged
group alone precludes binding of the lipoamide moiety of LBD to
the E1p active site. However, the structural basis for aborted
reductive acetylation in phospho-S1-E1p remains unknown.
S1-E1p Structure Is Unperturbed Compared
with Wild-Type E1p
To provide the structural basis for inactivation of the PDC by
phosphorylation, we determined five different crystal structures
Table 1. Kinetic Parameters for Wild-Type E1p, S1-E1p, and
Phospho-S1-E1p
Assays kcat (s
1)
Km for Pyruvate
(mM)
kcat/Km
(s1mM1)
Overall
WT E1p 21 ± 1 41 ± 4 0.51
Y89F-a E1p 19 ± 3 78 ± 13 0.24
S1-E1p 18 ± 2 58 ± 5 0.31
Phospho-S1-E1p NM NM -
DCPIP
WT E1p 0.26 ± 0.02 8.1 ± 0.5 0.032
Y89F-a E1p 2.7 ± 0.05 31 ± 5 0.087
S1-E1p 0.31 ± 0.02 9.5 ± 0.8 0.032
Phospho-S1-E1p 0.21 ± 0.01 281 ± 21 0.00075
Reductive acetylation
WT E1p 0.030 ± 0.002 - -
Y89F-a E1p 0.028 ± 0.002
S1-E1p 0.028 ± 0.001 - -
Phospho-S1-E1p NM - -
Phosphorylation studies on S1-E1p or Ser264-a (site 1) were carried out
using a double-alanine mutant S271A-a (site 2) and S203A-a (site 3). NM,
not measurable.1852 Structure 16, 1849–1859, December 10, 2008 ª2008 Elsevier Lof the human E1p heterotetramer: (1) wild-type E1p (containing
Mn-ThDP), (2) S1-E1p (containing Mg-ThDP), (3) phospho-S1-
E1p (containing Mn-ThDP), (4) ThDP-free (apo) phospho-S1-
E1p, and (5) apo Y89F-amutant E1p (Table 2). The last two struc-
tures (4 and 5) are described in the Supplemental Data available
online.
The overall structure of S1-E1p is compared with the present
wild-type E1p (Mn-ThDP) structure and two previously deter-
mined human E1p structures: wild-type E1p (Mg-ThDP; PDB
ID code 1NI4) (Ciszak et al., 2003) and S264E-a mutant E1p
(Mg-ThDP; PDB ID code 2OZL) (Ciszak et al., 2003; Seifert
et al., 2007). The rmsds between the S1-E1p structure and the
other three are less than 0.3 A˚ for over 1300 equivalent Ca atoms
in the E1p heterotetramer, indicating that the structure of S1-E1p
is essentially identical to that of the wild-type. Moreover, the con-
formations of the conserved Ph-loop A containing phosphoryla-
tion sites 1 and 2 (residues 259-a to 282-a) and Ph-loop B con-
taining phosphorylation site 3 (residues 198-a to 205-a) in the
E1p-a subunit are also unchanged in these structures (Figure 3A
and Figures S1A, S2A, and S2B). These findings suggest that
mutations to alanine at the phosphorylation sites 2 and 3 do
not perturb the E1p structure as also supported by the activity
data (Table 1).
Phosphorylation of S1-E1p Causes Disordering of the
Ph-Loops Harboring the Three Phosphorylation Sites
To examine the effect of ThDP binding on the conformation of
Ph-loops in E1p, it was necessary to produce the apo (without
the bound ThDP) form of E1p. Attempts to obtain completely
apo wild-type E1p by exhaustive dialysis in the presence of
EDTA were not successful because its nonphosphorylated
form has high binding affinity for Mg-ThDP (Kd = 0.11 mM)
(Table 3). In the wild-type E1p structure, Tyr89-a directly inter-
acts with the diphosphate group of the bound ThDP, but not
with either Ph-loop A or Ph-loop B (data not shown). Therefore,
we generated the Y89F-a mutant E1p, which exhibits 450-fold
weaker binding affinity for ThDP than the wild-type (Table 3). At
saturating ThDP concentrations, this mutant E1p shows essen-
tially wild-type activity levels in the overall reaction as well as
E1p-catalyzed decaroxylation and reductive acetylation (Ta-
ble 1). The Y89F-a E1p structure shows no electron density for
ThDP, Ph-loop A, and Ph-loop B, confirming the presence of
an apo form (Figure S1B). By contrast, in the wild-type holo-
E1p structure the Ph-loops are well ordered with the bound
ThDP (Figure 3A). Thus, the apo Y89F-a E1p structure supports
the thesis that the bound ThDP induces a disorder-to-order
transition of the Ph-loops, analogous to that observed in the
related E1b component of BCKDC (Li et al., 2004; Nakai et al.,
2004) (see the Supplemental Data for more details).
Crystals of phospho-S1-E1p were initially produced in the
presence of Mg-ThDP, but they did not contain the cofactor
and are thus also referred to as the apo form. In this structure,
the Ph-loops are completely or partially disordered (see Supple-
mental Data). This finding is in good agreement with 100-fold
weaker binding of phospho-S1-E1p for Mg-ThDP compared
with the wild-type (Table 3), establishing the important role of
the Ph-loops for ThDP binding (see below). However, the bound
ThDP is essential for ordering the Ph-loops as deduced from the
Y89F-a E1p structure (Figure S1B). It is therefore impossible totd All rights reserved
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Crystal Structures of Phospho-E1p ComponentTable 2. Data Collection and Refinement Statistics
WT E1p
(Mn-ThDP)
S1-E1p
(Mg-ThDP)
Phospho-S1-E1p
(apo)
Phospho-S1-E1p
(Mn-ThDP)
Y89F-a E1p
(apo)a
PDB ID code 3EXE 3EXF 3EXG 3EXH 3EXI
Data collectionb
Space group P21 P21 P1 C2 P3221
No. of E1p heterotetramers
in the asymmetric unit
2 2 8 2 0.5
(one heterodimer)
Unit cell
a (A˚) 103.57 103.39 119.28 154.38 257.06
b (A˚) 129.62 129.67 128.29 154.38 115.61
c (A˚) 124.30 144.95 228.41 82.95 127.59
a () 90 90 90.14 90 90
b () 92.48 109.16 90.05 90 113.64
g () 90 90 90.02 120 90
Wavelength (A˚) 0.98 0.98 0.98 1.54 (Cu-Ka) 0.98
Resolution (A˚) 1.98 3.0 3.0 2.45 2.20
Unique reflections 225,065 72,201 263,005 123,888 57,582
Completeness (%) 99.6 (99.0) 99.8 (98.2) 98.4 (98.0) 98.1 (96.6) 99.5 (99.5)
R-merge (%)c 10.7 (55.1) 14.6 (56.0) 8.0 (53.5) 15.5 (69.3) 3.4 (39.9)
s(I) 13.3 (2.3) 10.7 (2.6) 10.3 (1.7) 14.2 (2.8) 33.0 (2.0)
Multiplicity 4.9 (4.8) 3.7 (3.4) 2.1 (1.9) 6.7 (6.5) 6.6 (6.5)
Refinementb
No. reflections (work/test) 213,690/11,272 68,497/3,624 249,289/1,3221 117,572/6,182 55,098/1,511
No. atoms (mean B-value, A˚2)
Protein 21,379 (17.7) 21,386 (21.6) 83,323 (55.7) 5,106 (49.2) 21,081 (18.8)
Solvents 2,316 (26.5) 9 (6.9) 0 318 (51.0) 792 (19.0)
ThDP 104 (11.4) 104 (25.4) 0 0 104 (17.7)
Metal and other 32 (32.4) 8 (32.8) 16 (75.3) 3 (65.7) 58 (41.3)
R-work (%)d 15.8 (20.1) 18.4 (23.9) 18.9 (29.5) 16.5 (23.4) 18.7 (28.1)
R-free (%)d 20.6 (26.9) 26.2 (35.8) 25.3 (37.4) 21.0 (28.5) 22.5 (34.8)
Rmsd
Bond length (A˚) 0.021 0.021 0.019 0.020 0.020
Bond angle () 1.761 2.044 1.883 1.733 1.842
Ramachandran plot
Most favored (%) 96.5 90.2 92.1 96.1 96.3
Allowed (%) 2.2 6.8 5.7 2.8 2.5
Disallowed (%) 1.3 3.0e 2.2e 1.1 1.2
a This crystal contains a complex of Y89F-a E1p with SBD, but SBD is not visible and excluded from the model.
b Values in parentheses refer to data in the highest resolution shell unless otherwise indicated.
c R-merge = Shkl Sj j Ij  </> j / Shkl Sj Ij, where < /> is the mean intensity of j observations from a reflection hkl and its symmetry equivalents.
d R-work = Shkl j jFobsj  kjFcalcj j / Shkl jFobsj. R-free = R-work for 5% of reflections that were omitted from refinement.
e The higher numbers result from the lower resolution (3.0 A˚) of these structures than the others.discern whether the phosphorylation of site 1, the absence of
a bound ThDP, or a combination of the two induces the disorder-
ing of the Ph-loops in the apo phospho-S1-E1p structure. Be-
cause ThDP binds to phospho-S1-E1p with markedly higher
affinity in the presence of Mn2+ than Mg2+ (Figure S3), phos-
pho-S1-E1p was later crystallized at a saturating concentration
of Mn-ThDP.
Phospho-S1-E1p with bound Mn-ThDP crystallized with the
symmetry of space group C2 with two heterotetramers in the
asymmetric unit. The overall structure of phospho-S1-E1p isStructure 16, 1849–18similar to that of the wild-type (rmsd = 0.296 A˚ for 1379 equiva-
lent Ca atoms in the heterotetramer) and S1-E1p (rmsd = 0.268 A˚
for 1299 Ca atoms). However, the Ph-loops are significantly dif-
ferent. Among the four E1p-a subunits in the asymmetric unit,
three different conformations of the Ph-loops are observed. In
one of the E1p-a subunits, there is no discernable electron den-
sity for either Ph-loop A or Ph-loop B, indicating that these loops
are disordered (Figure 3C). However, the electron density for the
bound Mn-ThDP is well defined in all E1p heterotetramers.
Therefore, the bound cofactor does not seem to be able to order59, December 10, 2008 ª2008 Elsevier Ltd All rights reserved 1853
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Crystal Structures of Phospho-E1p Componentthe phosphorylated Ph-loops. There are no crystal-packing con-
tacts near both Ph-loops (Figure S4A). Taken together, the disor-
dered conformation appears to be an intrinsic property of the
phosphorylated Ph-loops.
Unexpectedly, the Ph-loops of two other E1p-a subunits
adopt wild-type-like conformations with electron densities of
the phosphoryl group on Ser264-a (site 1) clearly visible (Figures
3B and 4D and Figure S2C). These E1p-a subunits belong to dif-
ferent heterotetramers in the asymmetric unit and are related by
a 2-fold noncrystallographic symmetry axis (Figure S4B). The
a-helix in the ordered Ph-loop A in each E1p-a subunit interacts
with the neighboring heterotetramer, which appears to maintain
the Ph-loops in the wild-type ordered conformation. In the fourth
molecule, the Ph-loop A conformation is similar to the conforma-
tion with an extended a-helix observed in the apo phospho-S1-
E1p structure (see Supplemental Data, Figure 3D, and Figures
S1C and S2D). In this structure, the entire backbone of the
Ph-loop A has well-defined electron density, but the phosphoryl
group on Ser264-a is disordered. This variant Ph-loop A confor-
mation is also stabilized through interactions with a symmetry-
related molecule as observed in the corresponding apo structure
(Figures S4C). The physiological significance of this variant
Ph-loop A conformation is presently unclear.
Phosphorylation of Ser264-a Interferes
with the Ordering of the Ph-Loops
In our wild-type E1p structure, Ser264-a (site 1) and adjacent
Ser266-a in Ph-loop A form a hydrogen (H)-bond network with
two neighboring water molecules (Figure 4A). One of these water
molecules further establishes an H-bond with Tyr33-b0 from the
E1p-b0 subunit. A similar H-bond network is present in the
S264E-a mutant E1p structure, comprising residues Glu264-a,
Ser266-a, and Tyr33-b0 that coordinate to a water molecule (Fig-
ure 4B; Seifert et al., 2006). Ph-loop A in this mutant E1p struc-
ture is apparently stabilized by a variant H-bond network involv-
ing the introduced Glu264-a residue. By contrast, no bridging
water molecule between Ph-loop A and Tyr33-b0 is present in
the phospho-S1-E1p structure, which contains the wild-type-
like ‘‘ordered’’ Ph-loops stabilized by crystal packing
(Figure 4C). Moreover, the phosphoryl group of Ser264-a oc-
cupies the position where the side-chain hydroxyl group of
Ser266-a is located in the nonphosphorylated wild-type E1p
structure. This conformation potentially imposes a steric clash
between the bulky phosphoryl group and the side chain of
Ser266-a (Figure 4C). As a result, the hydroxyl group of
Ser266-a is rotationally disordered and exhibits poor electron
density (Figure 4D). The average B-factors of individual residues
in Ph-loops A and B of phospho-S1-E1p are significantly higher
than those of the equivalent regions in the nonphosphorylated
Figure 3. Structures of the Phosphorylation
loops in Wild-Type and Phospho-S1-E1p
The structures of Ph-loops in E1p-a subunits are
shown as ribbon models against other parts of
the protein in surface representation. Ph-loop A
(residues from 259-a to 282-a) is in orange, and
Ph-loop B (from 198-a to 205-a) in yellow. The
three phosphorylation sites are indicated by
spheres and labeled according to the site num-
bers. The bound ThDP is shown as a ball-and-
stick model.
(A) Fully ordered Ph-loops in wild-type E1p.
(B) Wild-type-like ordered Ph-loops in phospho-
S1-E1p with bound Mn-ThDP. Two of the four
E1p-a subunits in the asymmetric unit (depicted
as 2/4 in the figure caption) exhibit this conforma-
tion, which is maintained through interactions with
a symmetry-related molecule (Figure S3B).
(C) Completely disordered Ph-loops in phospho-
S1-E1p containing the bound Mn-ThDP. One of
the four E1p-a subunits in the asymmetric unit
(1/4) has this conformation. No symmetry-related
molecule is present near the Ph-loops
(Figure S3A).
(D) Variant-ordered conformation of Ph-loop A and
partially-ordered Ph-loop B in the remaining E1p-
a subunits (1/4). This conformation is also main-
tained by interactions with a symmetry-related
molecule (Figure S3C).
Table 3. Dissociation Constants for the Binding of Cofactor ThDP
to Wild-Type E1p, S1-E1p, and Phospho-S1-E1p in the Presence
of Magnesium Ions
Protein Kd (mM)
Maximum
quenching (%)
Wild-type E1p 0.11 ± 0.01 76.1 ± 2.1
Y89F-a E1p 50.2 ± 4.6 67.5 ± 2.3
S1-E1p 0.29 ± 0.02 68.4 ± 2.5
Phospho-S1-E1p 13.1 ± 1.1 73.1 ± 1.9
Dissociation constants (Kd) are determined by fluorescence quenching as
described in Experimental Procedures.1854 Structure 16, 1849–1859, December 10, 2008 ª2008 Elsevier Ltd All rights reserved
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Crystal Structures of Phospho-E1p ComponentFigure 4. Hydrogen-Bond Networks Involving Phosphorylation
Site 1
(A) The H-bond network connecting phosphorylation site 1 and Tyr33-b0 of the
E1p-b0 subunit in the wild-type E1p structure. Ph-loop A is in orange, and Ph-
loop B in yellow. The positions of the three phosphorylation sites are shown as
spheres at the corresponding Ca atom positions. Water molecules are de-
picted as small red spheres. H-bonds are indicated by gray dashed lines.
(B) A similar H-bond network in the Ser264E-a mutant E1p structure (PDB ID
code 2OZL; Seifert et al., 2007).
(C) A stereo diagram showing absence of the H-bond network in phospho-S1-
E1p containing bound Mn-ThDP. The phosphoryl group on Ser264-a (site 1)
clashes with the side chain of the neighboring Ser266-a. Van der Waals radii
of the phosphoryl group and side chains of both serine residues are shown
as spheres of red dots.
(D) A stereo figure of the 2Fo-Fc electron density map (contoured at 1s) at
phosphorylation site 1 with a stick representation of the refined model.Structure 16, 1849–18wild-type E1p-a subunit (Figure 4E). These findings indicate that
phosphorylated Ph-loop A and nonphosphorylated Ph-loop B
are both locally unstable, particularly in the vicinity of Ser266-a.
In the absence of crystal packing, phosphorylated Ph-loop A
remains in the disordered conformation, as observed in the other
phospho-S1-E1p-a subunit in the same crystal (Figure 3C). We
therefore conclude that phosphorylation of Ser264-a prevents
the ordering of both Ph-loops by ThDP in the phospho-S1-E1p
structure.
Concerted Disordering of Ph-Loops A and B Reduces
ThDP Binding to Phospho-S1-E1p
The disordering of Ph-loop B is tightly coupled to that of Ph-loop
A. This conjecture is based on the observations that Ph-loop B is
well defined when Ph-loop A is in the ordered wild-type confor-
mation in the crystal structures (Figures 3A and 3B and
Figure S1A). When Ph-loop A is disordered or in the variant
partially ordered conformation, Ph-loop B also assumes similar
conformations (Figures 3C and 3D and Figures S1B and S1C).
Ph-loop B extensively interacts with Ph-loop A through direct
and indirect H-bonds (Figure 5). Alterations in Ph-loop A confor-
mations apparently disrupt these interactions, producing recip-
rocal effects on the Ph-loop B conformation.
In the wild-type holo-E1p structure, the side chains of
Arg259-a and His263-a from Ph-loop A serve as key anchors
for the bound ThDP by forming indirect H-bonds with a phos-
phate of the bound ThDP through the same water molecule (Fig-
ure 5). The corresponding residues Arg287-a and His291-a in the
E1b component of BCKDC have been shown to be indispens-
able anchoring residues for ThDP binding (Li et al., 2004; Wynn
et al., 2003). In the Ph-loop B of wild-type E1p, the main-chain
carbonyl group of Tyr198-a provides a ligand to the cation ion
essential for ThDP binding (Figure 5). Thus, the disordering of
both Ph-loops A and Ph-loop B in phosphorylated E1p removes
these important anchors for the bound ThDP, resulting in weaker
binding affinity for this cofactor.
To further investigate these interactions, binding affinities of
wild-type E1p, S1-E1p, and phospho-S1-E1p for cofactor
ThDP in the presence of Mg2+ were measured by the quenching
of tryptophan fluorescence from residue Trp135-b0 of the E1p-b0
subunit upon ThDP binding (Table 3; Ali et al., 1995). Both wild-
type and S1-E1p exhibit high affinities for ThDP with dissociation
constants (Kd) of 0.11 mM and 0.29 mM, respectively. Phosphor-
ylation of S1-E1p increases the Kd for ThDP immensely by
more than 100-fold over wild-type E1p to 13.1 mM. The findings
suggest that the disruption of interactions between the anchoring
residues and ThDP by phosphorylation via the disordered Ph-
loops leads to the decreased binding affinity of E1p for ThDP.
In contrast, the introduction of a glutamate or glutamine to phos-
phorylation site 1 of E1p (S264E-a and S264Q-aE1p variants) did
not alter the affinity of the E1p mutants for ThDP, compared with
(E) Average B-factor plots of the wild-type and phospho-S1-E1p structures.
Average B-factors for individual residues in one of the four nonphosphorylated
wild-type E1p-a subunits (solid line) and one of the two phospho-S1-E1p-a
subunits with the wild-type-like ‘‘ordered’’ Ph-loops (dashed line) are plotted
against the residue number.
The residue ranges for Ph-loops A and B are indicated on top of the graph.
Each of the three phosphorylation sites and residue Ser266-a are labeled.59, December 10, 2008 ª2008 Elsevier Ltd All rights reserved 1855
Structure
Crystal Structures of Phospho-E1p Componentwild-type E1p at 0.47 mM (Seifert et al., 2007). The inability of the
amino acid substitution to induce the disordering of the Ph-loops
in the S264E-a E1p structure may explain the wild-type binding
affinities exhibited by these E1p mutants.
No Detectable L2 Binding to the Phosphorylated
S1-E1p Protein
Isothermal titration calorimetry (ITC) measurements were used
to characterize the binding of lipoylated L2 domain to wild-type
and phosphorylated E1p proteins in the presence of 200 mM
ThDP (Figure 6). Analysis of the data shows that both the wild-
type and nonphosphorylated S1-E1p proteins bind L2 with the
same affinity (Kd = 1.3 mM). By contrast, no heat changes were
detected for phosphorylated S1-E1p, consistent with the ab-
sence of L2 binding. The data provide evidence that the absence
of reductive acetylation (reaction 3) activity for ThDP in phos-
phorylated S1-E1p results from the inability of the substrate L2
to bind to E1p.
Structural Mechanism for Inactivation of E1p
by Phosphorylation
Based on the present biochemical and structural data, we pro-
pose the following structural mechanism by which phosphoryla-
tion of Ser264-a (site 1) inactivates the PDC. As shown in the
structure of the Y89F-a E1p mutant, the Ph-loops assume the
disordered conformation in the absence of the cofactor ThDP
(Figure 7A, left panel, and Figure S1B). We suggest that in
nonphosphorylated wild-type E1p, the Ph-loops are in equilib-
rium between the ordered and the disordered conformations.
ThDP binding induces the ordering of Ph-loops A and B through
(i) anchoring interactions provided by the bound ThDP via
His263-a and Arg259-a of Ph-loop A, (ii) coordination between
Tyr198-a of Ph-loop B and the bound magnesium or manganese
ion, and (iii) an H-bond network comprising Ser264-a, Ser266-a of
Ph-loop A, and Tyr33-b0 from the b0subunit (Figure 7A, middle
panel). The presence of both ordered Ph-loops confers the
essential determinants for binding of lip-LBD to E1p. With these
ordered Ph-loop conformations, E1p is able to catalyze both ox-
idative decarboxylation (reaction 2) and reductive acetylation
(reaction 3; Figure 7A, right panel).
The equilibrium between the disordered and the ordered loop
conformations may also exist in the E1 active sites of other
a-ketoacid dehydrogenase complexes, which are not regulated
by phosphorylation/dephosphorylation. A case in point, the acti-
vation loop, which is equivalent to Ph-loop A, has been shown to
assume both the disordered and the ordered conformations in
the E1p component of the Bacillus stearothermophilius PDC
(Frank et al., 2004, 2005). The premise is that these active-site
loops are intrinsically flexible by the necessity of the many roles
they play in catalysis, ThDP binding, and interactions with other
enzyme components.
When Ph-loop A is disordered in apo E1p, Ser264-a (site 1) is
readily available for phosphorylation by PDK (Figure 7B, left
panel). Upon phosphorylation, the bulky phosphoryl group could
Figure 5. Extensive Interactions between
the Two Ph-Loops in the Wild-Type E1p
Structure
The stereo diagram illustrates extensive interac-
tions between Ph-loop A (orange) and Ph-loop B
(yellow) in the nonphosphorylated wild-type E1p
structure. The Ph-loops are shown as stick
models. Side chains of some residues are omitted
for clarity. The three phosphorylation sites are
S264-a (site 1), S271-a (site 2), and S203-a (site
3). Water molecules are shown as small red
spheres, and the manganese atom as a pink
sphere. H-bonds are indicated by gray lines.
Figure 6. Binding of the Lipoylated-L2 Domain to E1p Determined by
Isothermal Titration Calorimetry
Wild-type E1p, S1-E1p, or phospho-S1-E1p protein (35 mM, heterodimer) was
titrated with 0.65 mM lip-L2 (residues 128–265 in E2p) as described in Exper-
imental Procedures. The binding isotherms were fit using ORIGIN version 7.0
software. For wild-type E1p and S1-E1p, the dissociation constants Kd are
averages of triplicates; for phospho-S1-E1p, there are no detectable heats.1856 Structure 16, 1849–1859, December 10, 2008 ª2008 Elsevier Ltd All rights reserved
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Site 1 Phosphorylation in E1p
(A) Reaction scheme for nonphosphorylated E1p.
The E1p active site is formed by portions of the
a subunit (green) and the b0 subunit (cyan). The
red arrow depicts the entrance of the active-site
channel for substrates pyruvate and lip-LBD. In
apo E1p, Ph-loops A (orange) and B (yellow) are
disordered (shown as dashed lines in the left
panel). Binding of the cofactor ThDP (magenta)
at the bottom of the active-site channel induces
ordering of Ph-loops A and B (middle panel). Phos-
phorylation sites are indicated by orange and yel-
low circles and numbered. Water molecules are
represented by red dots. H-bonds are shown as
dashed lines. These ordered Ph-loops mediate
E1p-catalyzed decarboxylation of pyruvate and
reductive acetylation of lip-LBD (right panel).
(B) Inactivation mechanism for phosphorylated
E1p. When Ph-loop A is disordered in apo E1p,
Ser264-a (site 1) is phosphorylatable by PDK
(from panel A, left, to panel B, left). A steric clash
between the phosphoryl group and adjacent Ser266-a prevents the ordering of Ph-loops (middle panel). In the absence of the ordered Ph-loops, ThDP binding
to the E1p active site is significantly attenuated (shown as a transparent oval). Under saturating ThDP conditions, the E1p-catalyzed decarboxylation of pyruvate
proceeds (right panel). However, the reductive acetylation of lip-LBD is abolished due to the loss of determinants on the disordered Ph-loops, which are essential
for lip-LBD binding to the E1p active site. The abrogation of E1p-catalyzed reductive acetylation interrupts substrate channeling in the PDC, resulting in the in-
activation of this catalytic machine.pose a steric clash with the side chain of Ser266-a (Figure 4). This
clash not only eliminates the H-bond network involving the serine
residue but also destabilizes the local conformation of Ph-loop A.
These negative effects prevent the disorder-to-order transition
of phosphorylated Ph-loop A, despite the presence of the bound
ThDP, leaving this loop in the disordered conformation
(Figure 7B, middle panel). Ph-loop B extensively interacts with
Ph-loop A (Figure 5), and therefore, the disordering of Ph-loop
A is coupled to that of Ph-loop B (Figure 3C). The disordering
of both Ph-loops synergistically decreases the binding affinity
of E1p for ThDP, through flexibility of the cofactor-anchoring res-
idues (Table 3). With reduced affinity for ThDP, phospho-S1-E1p
still catalyzes the decarboxylation of pyruvate (reaction 2) when
assayed at a saturating cofactor concentration (Figure 7B, right
panel, and Table 1). However, the reductive acetylation of lip-
LBD (reaction 3) by phospho-S1-E1p is nullified due to the dis-
placement of the critical determinants for lip-LBD binding to
the E1p active site (Figure 6). The interruption at the reductive
acetylation step forestalls the ensuing reaction steps (reactions
4–6) mediated by the E2p and E3 components, thereby abolish-
ing the overall activity (reaction 1) of the PDC.
Concluding Remarks
One of the remaining questions is whether the mechanism by
which phosphorylation at site 2 or site 3 leads to inactivation of
the PDC is similar to phosphorylation at site 1. Ser271-a (site
2) is involved in the H-bond network between Ph-loop A and
Ph-loop B (Figure 5). In addition, Ser271-a is close to Tyr33-b0,
which is involved in the neighboring H-bond network, including
Ser264-a (site 1) and Ser266-a (Figure 4). Phosphorylation of
Ser271-a could disrupt both the H-bond networks promoting
the disordering of both Ph-loops. On the other hand, Ser203-
a (site 3) is surrounded by Tyr198-a, Glu205-a, and several water
molecules, which invariably participate in the H-bond networkStructure 16, 1849–18between Ph-loop A and Ph-loop B (Figure 5). Phosphorylation
of site 3 could also revoke this H-bonding network and cause
the disordering of both Ph-loops. However, the deactivating ef-
fects of phosphorylation at site 2 or site 3 do not appear to be
as complete as those of site 1, because residual PDC activity
is present in either the site 2-only or site 3-only phosphorylated
E1p variants (Korotchkina and Patel, 2001b). The latter results,
and the slower rates of phosphorylation at site 2 and site 3
than site 1 (Korotchkina and Patel, 1995; Sale and Randle,
1981b), support the notion that site 1 is the major site for down-
regulation of PDC activity by phosphorylation.
The disordering of the Ph-loops in E1p is similar to that occur-
ring in the phosphorylated E1b component of BCKDC, which we
described previously (Wynn et al., 2004). The structural mecha-
nism for the disordering of the lone Ph-loop in E1b was not clear,
because in the absence of crystal contacts, the entire loop was
not visible upon phosphorylation. However, Ser264-a (site 1) and
the adjacent Ser266-a, which participate in the H-bond network
to stabilize Ph-loop A in the current wild-type E1p structure, are
conserved in the E1b component of BCKDC (Ser292-a and
Ser294-a, respectively). The conformation of the Ph-loop in
S292D-a E1b is maintained by a variant H-bond network pro-
duced by the side chains of the mutant aspartate and the juxta-
posed Ser294-a (Wynn et al., 2004), equivalent to the H-bond
network that stabilizes Ph-loop A in the pseudophosphorylated
S264E-a E1p structure (Seifert et al., 2007). Based on the pres-
ent findings with E1p, a steric clash between the phosphorylated
Ser292-a (site 1) and the side chain of Ser294-a would dislodge
a putative H-bond network in E1b, presumably resulting in the
disordered Ph-loop. Thus, the disordering of Ph-loops appears
to be the conserved mechanism between mammalian a-ketoa-
cid dehydrogenase complexes for inactivation by phosphoryla-
tion. Conversely, the disordering of Ph-loops upon phosphoryla-
tion is also necessary for reactivation through dephosphorylation59, December 10, 2008 ª2008 Elsevier Ltd All rights reserved 1857
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ruvate dehydrogenase phosphatase is located in the bottom of
a cavity and appears to be unable to accommodate the ordered
conformation of Ph-loops (Vassylyev and Symersky, 2007).
These findings, taken together, strongly suggest that the disor-
dering of Ph-loops is the unifying design for the regulation of
the mammalian PDC and BCKDC by reversible phosphorylation.
EXPERIMENTAL PROCEDURES
Materials
Pyruvate, thiamine diphosphate (ThDP), and 2,6-dichlorophenolindophenol
(DCPIP) were obtained from Sigma-Aldrich (St. Louis, MO). [g32P]ATP and
[2-14C]pyruvate were purchased from MP Biomedicals (Solon, OH). Expres-
sion plasmids for human wild-type E1p and E2p/E3BP (Harris et al., 1997)
were gifts from Kirill Popov (University of Alabama at Birmingham). Construc-
tion, expression, and purification of recombinant proteins are provided in the
Supplemental Data.
Phosphorylation of E1p
Phosphorylation of S1-E1p or S2-E1p was carried out with SUMO-PDK4,
and the degree of phosphorylation of E1p was estimated as described in the
Supplemental Data.
To scale up production of the fully phosphorylated protein, S1-E1p was in-
cubated with tag-free PDK4 and purified, as also described in the Supplemen-
tal Data.
Enzyme Assays
The activity assays for the overall reaction catalyzed by the PDC (reaction 1),
the E1p-catalyzed decarboxylation (reaction 2), and the E1p-catalyzed reduc-
tive acetylation of the lipoylated L2 domain (reaction 3) were conducted as
described in the Supplemental Data.
Fluorescence Quenching for ThDP Binding
Steady-state tryptophan fluorescence quenching upon ThDP binding to the
wild-type and mutant E1p proteins (87 nM, heterotetramer) was measured in
the presence of either Mg2+ or Mn2+ (1 mM) as described previously (Wynn
et al., 2003). Fluorescence was corrected for the inner-filter effect at high
ThDP concentrations (Lakowicz et al., 1983).
L2-Binding Measurement by ITC
ITC measurements were performed in a VP-ITC microcalorimeter from Micro-
Cal (Northampton, MA). Titrations were carried out in 50 mM potassium phos-
phate buffer (pH 7.5), 10 mM KCl, 200 mM ThDP, 2 mM MgCl2, and 5 mM b-mer-
captoethanol at 20C. In a typical measurement of lip-L2-E1p binding, 30
injections (at 3 min intervals) with 8 ml each of L2 (0.65 mM) were made into
1.8 ml of the E1p protein (35 mM, heterodimer) in the cell. Curve fitting and the
derivation of thermodynamic parameters were carried out with ORIGIN v. 7.0
software package providedby MicroCal. The concentrationsof human E1p pro-
teins and human lip-L2 were determined using extinction coefficients 3278nm of
145.7 mM1cm1 (base on tetramer) and 11.2 mM1cm1, respectively.
Structure Determination
Crystallization and data collection are provided in the Supplemental Data. The
E1p structures were determined by molecular replacement using the program
Phaser (Read, 2001) of the CCP4 package (CCP4, 1994) with the structure of
human E1p (PDB ID code 1NI4) as the search model. After rigid-body refine-
ment with REFMAC5 (Murshudov et al., 1997), the electron density map was
improved using the program DM (Cowtan and Main, 1996). The protein models
were manually modified using the program Coot (Emsley and Cowtan, 2004).
After modeling of the protein part was complete, ThDP, magnesium, or man-
ganese ions and water molecules were added in subsequent refinement
cycles. Data processing and refinement statistics are summarized in Table 2.
Structural representations were created with the program PyMOL (DeLano
Scientific, LLC; Palo Alto, CA).1858 Structure 16, 1849–1859, December 10, 2008 ª2008 ElsevierACCESSION NUMBERS
Coordinates and structure factors have been deposited in the Protein Data
Bank under accession codes 3EXE (wild-type E1p), 3EXF (S1-E1p), 3EXG
(apo phospho-S1-E1p), 3EXH (phospho-S1-E1p with Mn-ThDP), and 3EXI
(Y89F-a E1p).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Results, Supplemental Experimen-
tal Procedures, Supplemental References, and four figures and can be found
with this article online at http://www.cell.com/structure/supplemental/
S0969-2126(08)00415-2.
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